Cormedix Stock (NASDAQ: CRMD) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 584.983K |
Day Range | - - - |
52 Wk Range | 2.570 - 7.000 |
Market Cap | $289.750M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 15% |
Days to Cover | 21.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cormedix (NASDAQ: CRMD) through any online brokerage.
Other companies in Cormedix’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), Xeris Biopharma Holdings (NASDAQ:XERS) and Terns Pharma (NASDAQ:TERN).
The latest price target for Cormedix (NASDAQ: CRMD) was reported by JMP Securities on Tuesday, April 9, 2024. The analyst firm set a price target for 19.00 expecting CRMD to rise to within 12 months (a possible 260.53% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Cormedix (NASDAQ: CRMD) is $5.27 last updated April 22, 2024 at 4:59 PM EDT.
There are no upcoming dividends for Cormedix.
Cormedix’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Cormedix.
Cormedix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.